Andorra vs Barbados: Tuberculosis patients living with HIV receiving antiretroviral therapy
Andorra
0 patients
in 2021
Barbados
0 patients
in 2021
Andorra rank
141st
Barbados rank
141st
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Andorra
- Barbados
How they compare
Andorra currently reports 0 patients against 0 patients in Barbados, a difference of 0 patients.
Across all 15 years both countries report, Barbados has been ahead every year.
Andorra ranks 141st and Barbados ranks 141st of 183 countries.
Barbados has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Andorra | Barbados | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 patients | 1.33 patients | 1.33 patients | Barbados |
| 2010s | 0.1 patients | 0.8 patients | 0.7 patients | Barbados |
| 2020s | 0 patients | 0 patients | 0 patients | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Andorra or Barbados?
- Andorra, at 0 patients against 0 patients in Barbados as of 2021.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Andorra and Barbados?
- 0 patients, with Andorra ahead.
- How many years of comparable data are there for Andorra and Barbados?
- 15 years are reported by both, from 2007 to 2021.
- How do Andorra and Barbados rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Andorra ranks 141st and Barbados ranks 141st of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.